CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)

NCT ID: NCT04490317

Last Updated: 2024-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-29

Study Completion Date

2035-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective cohort study enrolls subjects who experience carbon monoxide (CO) poisoning. The purpose of the study is to evaluate therapeutic effects of various treatments and short and long-term outcomes in CO poisoned patients. In addition, complications of brain and heart susceptible to CO are investigated through various ways and the association between complications and the patient's prognosis is also investigated. All subjects will be regularly monitored by physicians participating in this study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective cohort study enrolls subjects who experience CO poisoning. The purpose of the study is to evaluate therapeutic effects of various treatments, including hyperbaric oxygen therapy (HBO), therapeutic hypothermia (TH), and additional drugs, and short and long-term outcomes, such as neurocognitive sequelae or mortality, in CO poisoned patients. In addition, complications of brain and heart susceptible to CO are investigated through a variety of ways, such as magnetic resonance image (MRI), computed tomography (CT), ultrasound, and laboratory test, and the association between various complications and the patient's prognosis is also investigated. All subjects will be regularly monitored by physicians participating in this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carbon Monoxide Poisoning Myocardial Injury Neurologic Deficits Image, Body Therapy Prognostic Factors Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acute CO poisoning

A diagnosis of CO poisoning is made according to medical history and carboxyhemoglobin \>5% (\>10% in smokers).

Cardiac MRI

Intervention Type DIAGNOSTIC_TEST

1. Cardiac MRI be taken to CO poisoned patients
2. Cardiac CT be taken to CO poisoned patients
3. TTE be taken to CO poisoned patients
4. Brain MRI be taken to CO poisoned patients
5. Neurocognitive function tests be taken to CO poisoned patients
6. Laboratory tests be taken to CO poisoned patients

Hyperbaric oxygen therapy

Intervention Type PROCEDURE

1. Hyperbaric oxygen therapy be used for CO poisoned patients
2. Therapeutic hypothermia be used for CO poisoned patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cardiac MRI

1. Cardiac MRI be taken to CO poisoned patients
2. Cardiac CT be taken to CO poisoned patients
3. TTE be taken to CO poisoned patients
4. Brain MRI be taken to CO poisoned patients
5. Neurocognitive function tests be taken to CO poisoned patients
6. Laboratory tests be taken to CO poisoned patients

Intervention Type DIAGNOSTIC_TEST

Hyperbaric oxygen therapy

1. Hyperbaric oxygen therapy be used for CO poisoned patients
2. Therapeutic hypothermia be used for CO poisoned patients

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cardiac CT Transthoracic echocardiography (TTE) Brain MRI Neurocognitive function tests Laboratory tests Therapeutic hypothermia

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute CO poisoning

Exclusion Criteria

* Declined to enrollment in the study
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wonju Severance Christian Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yong Sung Cha

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yong Sung Cha, MD

Role: PRINCIPAL_INVESTIGATOR

Wonju Severance Christian Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wonju Severance Christian Hospital

Wŏnju, Gangwon-do, South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yong Sung Cha, MD

Role: CONTACT

+82-33-741-1615

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yong Sung Cha, MD

Role: primary

+82-33-741-1615

References

Explore related publications, articles, or registry entries linked to this study.

Ahn GJ, Lee S, Heo YW, Cha YS. Mortality Risks and Causes in Previous Carbon Monoxide Poisoning: A Nationwide Population-Based Cohort Study. Crit Care Med. 2024 Dec 1;52(12):1866-1876. doi: 10.1097/CCM.0000000000006414. Epub 2024 Sep 18.

Reference Type DERIVED
PMID: 39298511 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CARE CO cohort

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dysfunctional Hemoglobin CO-ox
NCT02427685 COMPLETED